These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 36961658)
1. Immune Cells in Cardiac Injury Repair and Remodeling. Zambrano MA; Alcaide P Curr Cardiol Rep; 2023 May; 25(5):315-323. PubMed ID: 36961658 [TBL] [Abstract][Full Text] [Related]
2. Cells of the Immune System in Cardiac Remodeling: Main Players in Resolution of Inflammation and Repair After Myocardial Infarction. Kologrivova I; Shtatolkina M; Suslova T; Ryabov V Front Immunol; 2021; 12():664457. PubMed ID: 33868315 [TBL] [Abstract][Full Text] [Related]
4. Role of Cardiac Fibroblasts in Cardiac Injury and Repair. Han M; Zhou B Curr Cardiol Rep; 2022 Mar; 24(3):295-304. PubMed ID: 35028821 [TBL] [Abstract][Full Text] [Related]
13. Stimulating pro-reparative immune responses to prevent adverse cardiac remodelling: consensus document from the joint 2019 meeting of the ESC Working Groups of cellular biology of the heart and myocardial function. Steffens S; Van Linthout S; Sluijter JPG; Tocchetti CG; Thum T; Madonna R Cardiovasc Res; 2020 Sep; 116(11):1850-1862. PubMed ID: 32396608 [TBL] [Abstract][Full Text] [Related]
14. The effector cells and cellular mediators of immune system involved in cardiac inflammation and fibrosis after myocardial infarction. Liu Y; Xu J; Wu M; Kang L; Xu B J Cell Physiol; 2020 Dec; 235(12):8996-9004. PubMed ID: 32352172 [TBL] [Abstract][Full Text] [Related]
15. PUFA Supplementation and Heart Failure: Effects on Fibrosis and Cardiac Remodeling. Oppedisano F; Mollace R; Tavernese A; Gliozzi M; Musolino V; Macrì R; Carresi C; Maiuolo J; Serra M; Cardamone A; Volterrani M; Mollace V Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578843 [TBL] [Abstract][Full Text] [Related]
16. Novel roles of immunometabolism and nonmyocyte metabolism in cardiac remodeling and injury. Mouton AJ; Hall JE Am J Physiol Regul Integr Comp Physiol; 2020 Oct; 319(4):R476-R484. PubMed ID: 32877243 [TBL] [Abstract][Full Text] [Related]
17. Galectin-3 interferes with tissue repair and promotes cardiac dysfunction and comorbidities in a genetic heart failure model. Vlachou F; Varela A; Stathopoulou K; Ntatsoulis K; Synolaki E; Pratsinis H; Kletsas D; Sideras P; Davos CH; Capetanaki Y; Psarras S Cell Mol Life Sci; 2022 Apr; 79(5):250. PubMed ID: 35441327 [TBL] [Abstract][Full Text] [Related]
18. Pathological ventricular remodeling: mechanisms: part 1 of 2. Burchfield JS; Xie M; Hill JA Circulation; 2013 Jul; 128(4):388-400. PubMed ID: 23877061 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological and Activated Fibroblast Targeting of Gβγ-GRK2 After Myocardial Ischemia Attenuates Heart Failure Progression. Travers JG; Kamal FA; Valiente-Alandi I; Nieman ML; Sargent MA; Lorenz JN; Molkentin JD; Blaxall BC J Am Coll Cardiol; 2017 Aug; 70(8):958-971. PubMed ID: 28818206 [TBL] [Abstract][Full Text] [Related]
20. Immune Cells and Immunotherapy for Cardiac Injury and Repair. Rurik JG; Aghajanian H; Epstein JA Circ Res; 2021 May; 128(11):1766-1779. PubMed ID: 34043424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]